Ketoacidosis associated with type 2 sodium-glucose cotransporter inhibitors (SGLT2i) in patients aged 65 and older: Evidence from the French national pharmacovigilance database.
- DOI
- 10.1016/j.diabet.2025.101697
- Published
- 2025-08-18
- Container
- Diabetes Metab
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.diabet.2025.101697,
title = {Ketoacidosis associated with type 2 sodium-glucose cotransporter inhibitors (SGLT2i) in patients aged 65 and older: Evidence from the French national pharmacovigilance database.},
author = {Bassas Letissier N and Mirfendereski N and Laroche ML and Faillie JL and Paccalin M and Saulnier PJ and Allouchery M and Mosbah H.},
year = {2025},
journal = {Diabetes Metab},
doi = {10.1016/j.diabet.2025.101697},
url = {https://doi.org/10.1016/j.diabet.2025.101697}
}RIS
TY - JOUR TI - Ketoacidosis associated with type 2 sodium-glucose cotransporter inhibitors (SGLT2i) in patients aged 65 and older: Evidence from the French national pharmacovigilance database. AU - Bassas Letissier N AU - Mirfendereski N AU - Laroche ML AU - Faillie JL AU - Paccalin M AU - Saulnier PJ AU - Allouchery M AU - Mosbah H. PY - 2025 JO - Diabetes Metab DO - 10.1016/j.diabet.2025.101697 UR - https://doi.org/10.1016/j.diabet.2025.101697 ER -
APA
N, B. L., N, M., ML, L., JL, F., M, P., PJ, S., M, A., & H., M. (2025). Ketoacidosis associated with type 2 sodium-glucose cotransporter inhibitors (SGLT2i) in patients aged 65 and older: Evidence from the French national pharmacovigilance database.. Diabetes Metab. https://doi.org/10.1016/j.diabet.2025.101697
Source records
- europe-pmc · retrieved 2026-09-26T01:23:24.258Z
- hal · retrieved 2026-09-26T01:23:24.290Z
- hal · retrieved 2026-09-26T01:23:24.290Z